SHOULDER INNOVATIONS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
SHOULDER INNOVATIONS, INC. (SI) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.33 million shares as of 2026-01-30, per its 10-Q filed 2026-05-13.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-05-13
- SHOULDER INNOVATIONS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 466.99K shares, a 121.76% increase from fiscal 2024.
- SHOULDER INNOVATIONS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 210.59K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|
| 2026-01-30 | 1.33M shares 10-Q · filed 2026-05-13 | |
| 2025-12-31 | 466.99K shares 10-K · filed 2026-03-10 | |
| 2024-12-31 | 210.59K shares 10-K · filed 2026-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |